epirelefan40mg/1ml vial

Epirelefan is a pharmaceutical preparation containing Epirubicin Hydrochloride, a potent anthracycline cytotoxic agent used in chemotherapy. It works by intercalating into DNA and inhibiting topoisomerase II, which prevents DNA replication and transcription in rapidly dividing cancer cells. This medication is typically administered by healthcare professionals in a clinical setting for the treatment of various malignancies, including breast cancer, gastric cancer, and lymphomas. It is essential that administration is strictly supervised by an oncologist to manage potential systemic effects and ensure proper dosing based on the patient's body surface area and clinical condition.